Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Nov 18, 2020 1:35pm

98 Views

Post# 31923375

RE:RE:RE:RE:Type 1

Bio you must have missed the NR last fall showing cpeptide in the blood. Add an extension of warrants and an oversubscribed PP at 30c doesn't take a genius to figure out the trials are going well. I actually guessed 5 patients were enrolled after the extension of warrant news go back and look at my post if you like. My point is it doesn't mater what markets think the proof will be in the pudding.

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025